drugset / Trial / NCT02939248
Influence of Naloxone on Ticagrelor Pharmacokinetics and Pharmacodynamics in Patients With Unstable Angina Pectoris on Concomitant Treatment With Morphine
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate differences in the pharmacokinetics and pharmacodynamics of ticagrelor and its active metabolite between patients who received ticagrelor and morphine followed by naloxone versus patients treated with ticagrelor and morphine alone for unstable angina pectoris.
Timeline
- Start
- 2016-10
- Primary completion
- 2018-12
- Completion
- 2018-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Naloxone | Small molecule | 1 mg | Oral |
| Comparator | Ticagrelor | Small molecule | 180 mg | Oral |
| Comparator | Morphine | Other / unclassified | 5 mg | Intravenous |